{"id":49948,"date":"2022-10-23T13:02:05","date_gmt":"2022-10-23T11:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/"},"modified":"2022-10-23T13:02:05","modified_gmt":"2022-10-23T11:02:05","slug":"mevion-identifies-site-for-new-compact-proton-therapy-system-in-development","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/","title":{"rendered":"Mevion Identifies Site for New Compact Proton Therapy System in Development"},"content":{"rendered":"
\n

\nThe MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault.<\/i>\n<\/p>\n

LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO22<\/a>–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System\u2122 with HYPERSCAN\u00ae Pencil Beam Scanning (PBS). Stanford Health Care has been selected as the first site where the system will be developed and installed.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nProton therapy is a precise form of radiation therapy that reduces the amount of unnecessary radiation exposure to healthy tissue, which has the potential to decrease or eliminate the treatment side effects and lessen the risk of secondary malignancies.\n<\/p>\n

\nHistorically, the size, cost, and inherent complexity of proton technologies have limited the adoption of proton therapy. Mevion believes that the MEVION S250-FIT system has the potential to overcome the practical challenges of other technologies because the system is designed to be a more compact, affordable solution that can fit into an existing LINAC vault. Today, new proton therapy centers in the U.S. are almost exclusively compact single-room systems. Mevion\u2019s compact system would continue to advance the design and accessibility of proton therapy. The MEVION S250-FIT system is currently in development and has not received regulatory clearance for clinical use.\n<\/p>\n

\n\u201cMevion is dedicated to making proton therapy deployment similar to conventional radiation by simplifying room renovation requirements, enabling faster installation, and facilitating integration with other radiation therapy modalities,\u201d said Tina Yu, Ph.D., CEO and President of Mevion Medical Systems. \u201cThrough our arrangement with Stanford Health Care, Mevion is aiming to demonstrate that proton therapy can fit in an existing vault of a radiation oncology department and in turn become more accessible.\u201d\n<\/p>\n

\n*The MEVION S250-FIT Proton Therapy System has not received regulatory clearance.<\/i>\n<\/p>\n

\nAbout Mevion Medical Systems<\/b>\n<\/p>\n

\nSince 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com<\/a>.\n<\/p>\n

\nFollow us on Twitter: @MevionMedical<\/a>
Connect with us on LinkedIn: Mevion Medical Systems<\/a>
Like us on Facebook: MevionMedical<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJingyi Wang
\n
Mevion Medical Systems
\n
jwang@mevion.com<\/a>
978-540-1499\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault. LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO22–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System\u2122 with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49948","6":"format-standard","7":"category-industry"},"yoast_head":"\nMevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault. LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO22–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System\u2122 with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-23T11:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mevion Identifies Site for New Compact Proton Therapy System in Development\",\"datePublished\":\"2022-10-23T11:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/\"},\"wordCount\":427,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221023005057\\\/en\\\/1610803\\\/21\\\/2022-10-16-STILLVIEW_View01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/\",\"name\":\"Mevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221023005057\\\/en\\\/1610803\\\/21\\\/2022-10-16-STILLVIEW_View01.jpg\",\"datePublished\":\"2022-10-23T11:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221023005057\\\/en\\\/1610803\\\/21\\\/2022-10-16-STILLVIEW_View01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221023005057\\\/en\\\/1610803\\\/21\\\/2022-10-16-STILLVIEW_View01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mevion Identifies Site for New Compact Proton Therapy System in Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/","og_locale":"en_US","og_type":"article","og_title":"Mevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend","og_description":"The MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault. LITTLETON, Mass.–(BUSINESS WIRE)–#ASTRO22–Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System\u2122 with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-23T11:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mevion Identifies Site for New Compact Proton Therapy System in Development","datePublished":"2022-10-23T11:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/"},"wordCount":427,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/","url":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/","name":"Mevion Identifies Site for New Compact Proton Therapy System in Development - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg","datePublished":"2022-10-23T11:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221023005057\/en\/1610803\/21\/2022-10-16-STILLVIEW_View01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mevion-identifies-site-for-new-compact-proton-therapy-system-in-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mevion Identifies Site for New Compact Proton Therapy System in Development"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49948"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49948\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}